Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’
The Pharma Data
MAY 5, 2021
ChemoCentryx’s stock sinks as FDA flags issues with pivotal data ( Fierce ) ( BioCentury ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). . Experts Weigh In On Mixing And Matching COVID-19 Vaccines ( NPR ).
52 
Let's personalize your content